Evaluation of the thyroid nodule

Department of Internal Medicine, The Reading Hospital and Medical Center, West Reading, Philadelphia, USA.
Postgraduate medical journal (Impact Factor: 1.55). 05/2009; 85(1002):190-5. DOI: 10.1136/pgmj.2008.072140
Source: PubMed

ABSTRACT The annual incidence of thyroid cancer worldwide is 1 case per 100 000 men and 2.6 cases per 100 000 women. Most thyroid nodules are asymptomatic and are discovered incidentally on physical examination, self-palpation or incidentally on imaging studies performed for unrelated reasons. Although the majority of both palpable and non-palpable thyroid nodules are benign, approximately 5% may represent thyroid cancer. Thyroid-stimulating hormone, thyroid ultrasound and fine-needle aspiration biopsy are key tests to guide management. Physicians caring for patients with thyroid nodules need to develop a rational, cost-effective approach to ordering and interpreting imaging and diagnostic tests in the evaluation of the thyroid nodule.


Available from: Andy Donato, Dec 20, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: The detection of molecular alterations in the signaling pathways in thyroid carcinogenesis relates to some diagnostic, prognostic and treatment issues. The addition of the molecular profile to a well-differentiated thyroid cancer approach improves the accuracy of cancer detection, the prognostication and the selection of therapeutic targets for a more personalized management. It is expected that in the next few years, guidelines for thyroid cancer treatment will require a molecular marker panel to define the best treatment for this disease. BRAF and RAS mutations and RET/papillary thyroid cancer (PTC) and PAX8/PPARγ rearrangements, associated with the abnormal regulation of microRNA, constitute the most frequent molecular alterations identified in PTC. The clinical implications of the expression of these altered genes and molecules and the usefulness of these data for tailoring the approach to the disease and patient are the focus of this review.
    03/2013; 2(1):35-43. DOI:10.1007/s40136-013-0031-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: To examine the usefulness of dual-phase 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography (PET) for the evaluation of thyroid incidentalomas. In this retrospective study, cases with focal thyroid lesions seen incidentally at FDG PET in which the histopathological diagnosis was available and in which dual-phase FDG PET imaging was performed at 1 and 2 h after FDG injection were reviewed. In the included cases, the 1 and 2 h maximal standard uptake value (1-hour maximal SUV and 2-hour maximal SUV, respectively) and retention index (RI) were calculated, and the differences between benign and malignant thyroid incidentalomas were analysed. Receiver operating characteristic (ROC) analysis was performed to evaluate the ability of 1-hour maximal SUV, 2-hour maximal SUV, and RI to discriminate benign from malignant lesions. A total of 39 patients (25 females, 14 males) with 45 lesions (17 malignant, 28 benign) were included. In malignant thyroid incidentalomas, the average 1-hour maximal SUV, 2-hour maximal SUV, and RI were 5.20, 5.72, and 7.67%, respectively, and in benign thyroid incidentalomas the values were 4.67, 4.97, and 7.38%, respectively. There were no significant differences in 1-hour maximal SUV, 2-hour maximal SUV, and RI between benign and malignant lesions. The area under the ROC curve did not differ from 0.5. Dual-phase FDG PET is not useful for differentiating benign from malignant thyroid incidentalomas.
    Clinical Radiology 09/2011; 66(12):1197-202. DOI:10.1016/j.crad.2011.08.005 · 1.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To quantitatively assess the imaging characteristics of thyroid nodules in dual-energy computed tomography (CT) imaging for differentiation of benign and malignant lesions. Dual-energy CT imaging was performed on 97 surgically removed thyroid nodule specimens prior to their pathologic examination. Iodine- and water-based material decomposition images and 101 sets of pseudomonochromatic images of each thyroid specimen were reconstructed for quantitative imaging analysis. The iodine concentration and effective atomic number (Zeff) of thyroid nodules and surrounding normal thyroid tissues, HU curve slope (λHU), and mean CT values of nodules were compared between different pathologic categories. In the 97 specimens, a total of 169 nodules were confirmed pathologically, including 108 nodular goiters (group A), 47 follicular adenomas (group B), and 14 papillary carcinomas (group C). Statistical analysis showed a significant difference between benign (A and B) and malignant (C) groups in iodine concentration (P < 0.001), λHU (P < 0.001), and Zeff (P < 0.001). For mean CT values, there existed statistical difference between groups A and C, but no difference between groups B and C. No statistical significance was found at iodine concentrations, the Zeff, or λHU in thyroid tissues surrounding nodules (P > 0.10). Additionally, water content was constant and homogeneous in nodules and adjacent thyroid tissues (P > 0.10). Pseudomonochromatic imaging reconstruction and material decomposition-based quantitative dual-energy CT imaging have promising potential for diagnostic differentiation of benign and malignant thyroid nodules.
    Investigative radiology 07/2011; 47(1):58-64. DOI:10.1097/RLI.0b013e318229fef3 · 4.45 Impact Factor